Literature DB >> 16178376

Cerebral phaeohyphomycosis caused by Fonsecaea monophora.

S Surash1, A Tyagi, G S De Hoog, J S Zeng, R C Barton, R P Hobson.   

Abstract

We report a case of cerebral phaeohyphomycosis in a 53-year-old immunocompetent diabetic male, caused by Fonsecaea monophora. Computerized tomography of the brain revealed an abscess, which yielded F. monophora in pure culture. The patient's condition deteriorated on treatment with voriconazole and 5-fluorocytosine, and improved subsequently with high-dose itraconazole. The genus Fonsecaea has recently been revised and the new species F. monophora generated from molecular analysis of isolates, most of which were originally identified as Fonsecaea pedrosoi. This is the fourth case of cerebral infection known to have been caused by F. monophora, although only the first reported as such. These cases suggest that the clinical potential of F. monophora differs from that of F. pedrosoi, one of the main agents of chromoblastomycosis, with F. monophora being predominantly neurotropic in the human host.

Entities:  

Mesh:

Year:  2005        PMID: 16178376     DOI: 10.1080/13693780500220373

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  29 in total

1.  The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.

Authors:  S Schwartz; A Reisman; P F Troke
Journal:  Infection       Date:  2011-04-22       Impact factor: 3.553

2.  Phylogenomic analyses reveal the diversity of laccase-coding genes in Fonsecaea genomes.

Authors:  Leandro Ferreira Moreno; Peiying Feng; Vinicius Almir Weiss; Vania Aparecida Vicente; J Benjamin Stielow; Sybren de Hoog
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240

3.  Severe disseminated phaeohyphomycosis in an immunocompetent patient caused by Veronaea botryosa.

Authors:  Alexandro Bonifaz; Mehrnaz Mohammad Davoudi; G S de Hoog; Carmen Padilla-Desgarennes; Denisse Vázquez-González; Gisela Navarrete; Jacques F Meis; Hamid Badali
Journal:  Mycopathologia       Date:  2013-03-08       Impact factor: 2.574

4.  Respiratory Tract Infection Caused by Fonsecaea monophora After Kidney Transplantation.

Authors:  Isabella Barbosa Cleinman; Sarah Santos Gonçalves; Marcio Nucci; Danielle Carvalho Quintella; Márcia Halpern; Tiyomi Akiti; Glória Barreiros; Arnaldo Lopes Colombo; Guilherme Santoro-Lopes
Journal:  Mycopathologia       Date:  2017-06-28       Impact factor: 2.574

5.  Molecular cloning, characterization and differential expression of Cdc42 in Fonsecaea monophora.

Authors:  Zhi Xie; Peiying Feng; Junming Zhang; Xiqing Li; Jiufeng Sun; Changming Lu; Huaiqiu Huang; Liyan Xi
Journal:  Mol Biol Rep       Date:  2011-05-15       Impact factor: 2.316

Review 6.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 7.  Fungal infections of the CNS: treatment strategies for the immunocompromised patient.

Authors:  Katharine E Black; Lindsey R Baden
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 8.  Chromoblastomycosis as an endemic disease in temperate Europe: first confirmed case and review of the literature.

Authors:  M Pindycka-Piaszczyńska; P Krzyściak; M Piaszczyński; S Cieślik; K Januszewski; G Izdebska-Straszak; J Jarząb; S de Hoog; T Jagielski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-19       Impact factor: 3.267

9.  Murine model of a disseminated infection by the novel fungus Fonsecaea monophora and successful treatment with posaconazole.

Authors:  Enrique Calvo; F Javier Pastor; M Mar Rodríguez; Emilio Mayayo; Valentina Salas; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

10.  In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.

Authors:  Mohammad J Najafzadeh; Hamid Badali; Maria Teresa Illnait-Zaragozi; G Sybren De Hoog; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.